إعلان
إعلان
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
78.18
USDبرعاية
-0.81
-1.03%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
77.39
-0.79
-1.01%
تقارير أرباح MIRM
النسبة الإيجابية المفاجئة
MIRM تفوق 13 من 26 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$138.44M
/-$0.06
التغير الضمني من Q3 25 (Revenue/ EPS)
+4.08%
/-220.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+39.25%
/-87.76%
Mirum Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, MIRM reported earnings of 0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 129.76% surprise. Revenue reached 133.01 مليون, compared to an expected 132.68 مليون, with a 0.25% difference. The market reacted with a -1.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 138.44 مليون USD, implying an decrease of -220.00% EPS, and increase of 4.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Mirum Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Mirum Pharmaceuticals, Inc. Common Stock reported EPS of $0.05, beating estimates by 129.76%, and revenue of $133.01M, 0.25% above expectations.
How did the market react to Mirum Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.24%, changed from $70.97 before the earnings release to $70.09 the day after.
When is Mirum Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Mirum Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 12
analysts, Mirum Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $138.44M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان